FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

502511000001108: Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1859041000001115 Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1859051000001117 Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Is a Product containing precisely moclobemide 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Moclobemide false Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Moclobemide true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) 30 tablet 3 x 10 tablets Is pack of False Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) 30 tablet 3 x 10 tablets Has AMP True Moclobemide 300mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start